GO is the most frequent extrathyroidal manifestation of Graves' disease, although it may
rarely occur in euthyroid/hypothyroid patients with chronic autoimmune thyroiditis. It is a …

Graves' orbitopathy (GO) is an orbital autoimmune disorder and the main extrathyroidal
manifestation of Graves' disease, the most common cause of hyperthyroidism. GO affects …

Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease (GD).
Choice of treatment should be based on the assessment of clinical activity and severity of …

Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage.
Novel therapies have recently emerged, and their specific roles are still being determined …

Objective: To develop evidence-based recommendations for safe, effective, and appropriate
thyroidectomy. Background: Surgical management of thyroid disease has evolved …

Objective Thyroid eye disease (TED) is a debilitating condition that frequently manifests in
patients suffering from Graves' disease (GD). This study aims to analyse the prevalence of …

Graves' ophthalmopathy (GO) is an autoimmune inflammatory disorder associated with
thyroid disease which affects ocular and orbital tissues. GO follows a biphasic course in …

Graves disease is the most common cause of hyperthyroidism in iodine-sufficient areas. The
main responsible mechanism is related to autoantibodies that bind and activate the …

Background: Considerable uncertainty remains about the pattern of use of treatment options
for Graves' disease (GD) and their comparative effectiveness and safety. Methods: Between …

Purpose Our understanding of thyroid-associated ophthalmopathy (TAO, AKA Graves'
orbitopathy, thyroid eye disease) has advanced substantially, since one of us (TJS) wrote …